Transcriptional Programs Define Intratumoral Heterogeneity of Ewing Sarcoma at Single-Cell Resolution

Marie-Ming Aynaud1, Olivier Mirabeau1, Nadege Gruel2

  • 1INSERM U830, Équipe Labellisée LNCC, SIREDO Oncology Centre, Institut Curie, 75005 Paris, France.

Cell Reports
|February 13, 2020
PubMed

Insights

Ewing sarcoma (EwS) cells show varied gene activity despite genetic similarity. This study maps the EWSR1-FLI1 oncogene

Area of Science:

  • Cancer Biology
  • Molecular Oncology
  • Genomics

Background:

  • Ewing sarcoma (EwS) is driven by the EWSR1-FLI1 oncogene, which causes cell transformation.
  • The mechanisms by which genetically uniform EwS cells generate diverse transcriptional programs remain unclear.
  • Understanding this heterogeneity is crucial for developing targeted therapies.

Purpose of the Study:

  • To characterize dynamic cellular processes linked to EWSR1-FLI1 activity.
  • To define the specific enhancer-driven EWSR1-FLI1 program.
  • To identify sources of intratumoral heterogeneity in EwS.

Main Methods:

  • Integration of independent component analysis on single-cell RNA sequencing data.
  • Time-resolved mapping of EWSR1-FLI1 binding sites.
  • Analysis of open chromatin regions across diverse cell types and model systems.

Main Results:

  • A specific, direct enhancer-driven EWSR1-FLI1 program was defined.
  • In EwS tumors, high cell proliferation and oxidative phosphorylation correlate with a defined EWSR1-FLI1 activity range.
  • A subpopulation of cells with altered EWSR1-FLI1 activity exhibits increased hypoxia.

Conclusions:

  • EWSR1-FLI1 activity directly influences distinct cellular states within EwS tumors.
  • Heterogeneity in EwS is partly driven by variations in EWSR1-FLI1 activity and associated metabolic states.
  • These findings provide insights into the molecular basis of EwS intratumoral heterogeneity.

Related Concept Videos